Skip to content
Open access

Echocardiographic HFpEF phenotype in people with HIV: prevalence and associated factors in the COCOMO cohort

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

In PWH, a modified HFA-PEFF approach identified an HFpEF echocardiographic phenotype in nearly half of participants despite a predominantly middle-aged cohort, independently associated with cardiometabolic comorbidity and prior AIDS, but not with symptoms or biomarkers.

Abstract

People with HIV (PWH) are at increased risk of heart failure despite effective antiretroviral therapy. Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in aging populations; however, its prevalence and associated clinical features in contemporary PWH are not well defined. To assess the prevalence and correlates of an echocardiographic HFpEF phenotype in PWH using a modified Heart Failure Association (HFA)-PEFF score. We included 528 PWH with LVEF ≥50% from a prospective, observational cohort. All participants underwent comprehensive echocardiography, physical examination, blood sampling, and questionnaire-based assessment of dyspnea. The modified HFA-PEFF score was calculated using only the structural and functional echocardiographic domains (excluding the natriuretic peptide domain), with a maximum of 2 points per domain. Participants were classified as low (0–1 points), intermediate (2–3 points), or high (4 points) probability of HFpEF. Dyspnea was categorized as mild (hurrying/uphill) or moderate/severe (walking at usual pace or at rest). Unadjusted trends in baseline characteristics across modified HFA-PEFF categories were assessed using regression models treating score category as an ordinal variable. Associations between clinical and HIV-related characteristics and an echocardiographic HFpEF phenotype (HFA-PEFF score 2–4 vs 0–1) were evaluated using multivariable logistic regression adjusted for age, sex, BMI, hypertension, diabetes, eGFR, and smoking status. Mean age was 53 ± 11 years, and 88% were male. Modified HFA-PEFF scores were low in 287 (54%), intermediate in 221 (42%), and high in 20 (4%). Increasing modified HFA-PEFF score was associated with older age, higher BMI, hypertension, diabetes, lower eGFR, longer HIV duration, prior AIDS, and higher NT-proBNP and troponin T, whereas dyspnea prevalence did not differ across categories (Table 1). In multivariable logistic models, age (aOR 2.39 [1.88–3.07] per 10-year increase), BMI (aOR 1.52 [1.11–2.09] per 5 kg/m² increase), hypertension (aOR 2.04 [1.35–3.10]) and prior AIDS (aOR 2.19 [1.22–4.00]) were associated with an HFpEF phenotype. HIV duration, CD4 nadir <200 cells/μL, biomarkers, and dyspnea were not associated (Figure 1). In PWH, a modified HFA-PEFF approach identified an HFpEF echocardiographic phenotype in nearly half of participants despite a predominantly middle-aged cohort. The phenotype was independently associated with cardiometabolic comorbidity and prior AIDS, but not with symptoms or biomarkers.

Read PDF

Similar papers

Oct 2026

Unrecognized heart failure with preserved ejection fraction in COPD: phenotyp-ing a prospective cohort using the HFA-PEFF score

In a COPD population without known heart failure, higher HFpEF probability was common and associated with cardiopulmonary risk factors, impaired cardiac function, and worse clinical outcomes, according to the HFA-PEFF score.

L. S. Duus, D. Vesterlev, E. H. Janner et al. · 0 citations
Open access Oct 2026

Diagnostic performance of the H2FPEF score and cardiovascular burden in patients with chronic kidney disease: a cross-sectional study

In patients with moderate-to-advanced CKD, previously unrecognised HFpEF was identified in approximately half of participants using guideline-based diagnostic criteria, supporting its role as a rule-in rather than rule-out tool in CKD.

M. Covic, A. Stefan, G. Dodi et al. · 0 citations
Open access Nov 2026

Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension

ABSTRACT Background Chronic thromboembolic pulmonary hypertension (CTEPH) and left heart disease, particularly heart failure with preserved ejection fraction (HFpEF), show overlapping clinical features despite distinct pathophysiology. Objectives The HFpEF‐ABA algorithm (age, body mass index, atrial fibrillation) was u...

Yi-Jia Wang, Xin Li, Z. Huang et al. · 0 citations
Open access Oct 2026

Association of Anemia with Clinical, Laboratory, and Echocardiographic Characteristics in Patients with Heart Failure with Preserved Ejection Fraction: A Cross-Sectional Study

Objective: To determine the prevalence and severity of anemia among patients with heart failure with preserved ejection fraction (HFpEF) and evaluate its associations with clinical characteristics, laboratory biomarkers, and echocardiographic parameters. Methodology: This hospital-based cross-sectional study included 9...

K. Shaikh, Noman Ahmed, Abdul Basit et al. · 0 citations
Open access Oct 2026

Improving outcomes in HFpEF with advanced CKD: temporal trends from the SHEBAHEART Registry

Patients with advanced chronic kidney disease (CKD) and heart failure (HF) are systematically underrepresented in clinical trials despite comprising a substantial proportion of real-world HF populations [1]. Whether contemporary care has translated into improved outcomes in this high-risk group particularly among...

D. Hochstein, D. Sternik, V. Copeland et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.